Cribstone Capital Management, LLC Astrazeneca PLC Transaction History

Cribstone Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $290 - $361	-6 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$43.1 - $55.31 $258 - $331	6 New	6 $0
Q1 2020 Apr 21, 2020	SELL	$37.79 - $51.33 $1,889 - $2,566	-50 Closed	0 $0
Q3 2019 Nov 20, 2019	SELL	$40.12 - $45.47 $8,023 - $9,094	-200 Reduced 80.0%	50 $2,000
Q2 2019 Jul 22, 2019	SELL	$37.28 - $41.68 $3,728 - $4,168	-100 Reduced 28.57%	250 $10,000
Q3 2017 Oct 30, 2017	BUY	$28.96 - $34.0 $10,136 - $11,900	350	350 $12,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cribstone Capital Management, LLC with notifications on news.